These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 35464465)

  • 1. Chaperones and Catalysts: How Antigen Presentation Pathways Cope With Biological Necessity.
    Margulies DH; Taylor DK; Jiang J; Boyd LF; Ahmad J; Mage MG; Natarajan K
    Front Immunol; 2022; 13():859782. PubMed ID: 35464465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and dynamic studies of TAPBPR and Tapasin reveal the mechanism of peptide loading of MHC-I molecules.
    Margulies DH; Jiang J; Natarajan K
    Curr Opin Immunol; 2020 Jun; 64():71-79. PubMed ID: 32402827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chaperone function in antigen presentation by MHC class I molecules-tapasin in the PLC and TAPBPR beyond.
    Margulies DH; Jiang J; Ahmad J; Boyd LF; Natarajan K
    Front Immunol; 2023; 14():1179846. PubMed ID: 37398669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural aspects of chaperone-mediated peptide loading in the MHC-I antigen presentation pathway.
    Natarajan K; Jiang J; Margulies DH
    Crit Rev Biochem Mol Biol; 2019 Apr; 54(2):164-173. PubMed ID: 31084439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAPBPR alters MHC class I peptide presentation by functioning as a peptide exchange catalyst.
    Hermann C; van Hateren A; Trautwein N; Neerincx A; Duriez PJ; Stevanović S; Trowsdale J; Deane JE; Elliott T; Boyle LH
    Elife; 2015 Oct; 4():. PubMed ID: 26439010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tapasin-related protein TAPBPR is an additional component of the MHC class I presentation pathway.
    Boyle LH; Hermann C; Boname JM; Porter KM; Patel PA; Burr ML; Duncan LM; Harbour ME; Rhodes DA; Skjødt K; Lehner PJ; Trowsdale J
    Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3465-70. PubMed ID: 23401559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualising tapasin- and TAPBPR-assisted editing of major histocompatibility complex class-I immunopeptidomes.
    van Hateren A; Elliott T
    Curr Opin Immunol; 2023 Aug; 83():102340. PubMed ID: 37245412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAPBPR promotes antigen loading on MHC-I molecules using a peptide trap.
    McShan AC; Devlin CA; Morozov GI; Overall SA; Moschidi D; Akella N; Procko E; Sgourakis NG
    Nat Commun; 2021 May; 12(1):3174. PubMed ID: 34039964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chaperone-mediated MHC-I peptide exchange in antigen presentation.
    Jiang J; Natarajan K; Margulies DH
    IUCrJ; 2024 May; 11(Pt 3):287-298. PubMed ID: 38656309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and Function of Molecular Chaperones that Govern Immune Peptide Loading.
    Margulies DH; Jiang J; Natarajan K
    Subcell Biochem; 2019; 93():321-337. PubMed ID: 31939156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A loop structure allows TAPBPR to exert its dual function as MHC I chaperone and peptide editor.
    Sagert L; Hennig F; Thomas C; Tampé R
    Elife; 2020 Mar; 9():. PubMed ID: 32167472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of TAPBPR, a tapasin homolog, with MHC-I molecules promotes peptide editing.
    Morozov GI; Zhao H; Mage MG; Boyd LF; Jiang J; Dolan MA; Venna R; Norcross MA; McMurtrey CP; Hildebrand W; Schuck P; Natarajan K; Margulies DH
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):E1006-15. PubMed ID: 26869717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of peptide loading into major histocompatibility complex class I molecules chaperoned by TAPBPR.
    Xu H; Song K; Da LT
    Phys Chem Chem Phys; 2022 May; 24(20):12397-12409. PubMed ID: 35575131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAPBPR employs a ligand-independent docking mechanism to chaperone MR1 molecules.
    McShan AC; Devlin CA; Papadaki GF; Sun Y; Green AI; Morozov GI; Burslem GM; Procko E; Sgourakis NG
    Nat Chem Biol; 2022 Aug; 18(8):859-868. PubMed ID: 35725941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilizing TAPBPR to promote exogenous peptide loading onto cell surface MHC I molecules.
    Ilca FT; Neerincx A; Wills MR; de la Roche M; Boyle LH
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9353-E9361. PubMed ID: 30213851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Get into the groove! The influence of TAPBPR on cargo selection.
    Satti R; Morley JL; Boyle LH
    Curr Opin Immunol; 2023 Aug; 83():102346. PubMed ID: 37295041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of a TAPBPR-MHC I complex reveals the mechanism of peptide editing in antigen presentation.
    Jiang J; Natarajan K; Boyd LF; Morozov GI; Mage MG; Margulies DH
    Science; 2017 Nov; 358(6366):1064-1068. PubMed ID: 29025991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC I chaperone complexes shaping immunity.
    Thomas C; Tampé R
    Curr Opin Immunol; 2019 Jun; 58():9-15. PubMed ID: 30771631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAPBPR: a new player in the MHC class I presentation pathway.
    Hermann C; Trowsdale J; Boyle LH
    Tissue Antigens; 2015 Mar; 85(3):155-66. PubMed ID: 25720504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential interaction of MHC class I with TAPBPR in the absence of glycosylation.
    Neerincx A; Boyle LH
    Mol Immunol; 2019 Sep; 113():58-66. PubMed ID: 30077416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.